Vaniqa Rx Facial Hair Remover May Be Strong OTC Switch Candidate
This article was originally published in The Rose Sheet
Executive Summary
Ongoing studies on Bristol-Myers Squibb's newly approved Vaniqa prescription hair removal drug could broaden the target consumer of the topical cream to include men. FDA approved the product for removal of women's facial hair July 27.